Ownership and insider activity for MapLight Therapeutics, Inc. (MPLT): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative treatments for individuals grappling with severe central nervous system (CNS) disorders. Its pipeline features several promising therapeutic candidates: ML-007C-MA, a fixed-dose combination of an M1/M4 muscarinic agonist, is being advanced to address symptoms of schizophrenia and Alzheimer's disease psychosis.
Price
| Price | $11.40 |
| Market Cap | $484M |
| Exchange | NASDAQ |
| Country | US |
Balance Sheet (10y)
| Year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Cash & Equivalents | $27.7M | $79.8M | $38.3M | $46.7M |
| Short-term Investments | 0 | 0 | $70.5M | $258.4M |
| Receivables | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 |
| Total Current Assets | $32.0M | $83.6M | $114.6M | $324.7M |
| Property, Plant & Equipment | $7.1M | $6.6M | $7.6M | $6.6M |
| Goodwill | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 |
| Total Assets | $39.4M | $91.4M | $136.9M | $479.5M |
| Accounts Payable | 0 | 0 | $1.9M | 0 |
| Short-term Debt | $348000 | $495000 | $778000 | $891000 |
| Total Current Liabilities | $12.6M | $14.7M | $15.9M | $16.2M |
| Long-term Debt | 0 | 0 | 0 | 0 |
| Total Liabilities | $18.5M | $20.1M | $21.7M | $21.1M |
| Retained Earnings | -$66.1M | -$121.8M | -$199.4M | -$360.5M |
| Total Equity | $20.9M | $71.3M | $115.2M | $458.4M |
| Total Debt | $6.3M | $5.9M | $6.6M | $5.8M |
| Net Debt | -$21.4M | -$73.8M | -$102.2M | -$299.3M |
| Working Capital | $19.4M | $68.9M | $98.7M | $308.4M |
Financial Health
| Debt / Equity | 0.01 |
| Current Ratio | 16.52 |
| Piotroski F-Score | 3 |
| Altman Z-Score | 20.51 |
Profitability
| Return on Equity | -35.16% |
| Return on Invested Capital | -36.43% |
| Return on Assets | -33.61% |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Related companies: BRTX · DWTX · EDSA · ERNA · IMRN · LPCN · OSRH
Explore sector: Healthcare · Biotechnology
More sections of MPLT: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks